Effet de l'almitrine per os sur le syndrome d'apnée du sommeil [Effect of oral almitrine on the sleep apnea syndrome].

Details

Serval ID
serval:BIB_CCD071A6F1BE
Type
Article: article from journal or magazin.
Collection
Publications
Title
Effet de l'almitrine per os sur le syndrome d'apnée du sommeil [Effect of oral almitrine on the sleep apnea syndrome].
Journal
Revue Française des Maladies Respiratoires
Author(s)
Mangin P., Krieger J., Kurtz D.
ISSN
0301-0279 (Print)
ISSN-L
0301-0279
Publication state
Published
Issued date
1983
Volume
11
Number
6
Pages
899-906
Language
french
Notes
Publication types: Clinical Trial ; Controlled Clinical Trial ; English Abstract ; Journal Article
Publication Status: ppublish
Abstract
Almitrine stimulates breathing by activating peripheral chemoreceptors and was given orally in a dose of 200 mg/day to nine patients with sleep apnoea syndrome, after a single blind placebo sequence. No reduction in the number of respiratory events per hour of sleep was observed. On the other hand Almitrine led to a significant fall in the mean duration of respiratory events (p less than 0.02). This fall occurred principally in the obstructive apnoea group and in those with mixed apnoea only during light slow wave sleep. These results are in agreement with the hypothesis that the arousal response to hypoxia mediated by the chemoreceptors could be responsible for the termination of sleep apneas.
Keywords
Aged, Almitrine, Central Nervous System Stimulants/therapeutic use, Chemoreceptor Cells/physiology, Humans, Male, Middle Aged, Piperazines/therapeutic use, Respiration, Sleep Apnea Syndromes/drug therapy, Sleep Apnea Syndromes/physiopathology, Sleep Stages/physiology
Pubmed
Create date
11/10/2010 16:35
Last modification date
20/08/2019 16:47
Usage data